Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating activities:
Net income	$ (410,000)	$ 165,000	$ 3,423,000	$ 88,000
Adjustments to reconcile net income to net cash from operating activities:
Depreciation, amortization, and other	1,644,000	1,265,000	4,501,000	3,874,000
Loss on write down of impaired assets and associated removal costs, net	0	0	188,000	578,000
Accretion of debt issuance costs	19,000	7,000	77,000	44,000
Bargain purchase gain RI Acquisition, net of deferred income taxes	(263,000)	0	(3,942,000)	0
Non cash lease expense			219,000	231,000
Accretion of unfavorable lease position			(26,000)
Deferred income taxes			183,000	0
Stock-based compensation expense			285,000	291,000
Changes in operating assets and liabilities:
Receivables			(3,975,000)	(498,000)
Prepaid expenses and other assets			148,000	799,000
Asset retirement obligations, related party			(113,000)	578,000
Related party liabilities			(2,006,000)	2,291,000
Accounts payable, accrued liabilities, and deferred revenue			2,379,000	713,000
Income taxes payable			(1,229,000)	54,000
Lease liabilities			(219,000)	(265,000)
Net cash (used in) provided by operating activities			(107,000)	8,778,000
Investing activities:
Cash received in excess of cash paid for the RI Acquisition			538,000	0
Payment for purchases of property and equipment			(3,278,000)	(6,176,000)
Net cash used in investing activities			(2,740,000)	(6,176,000)
Financing activities:
Principal payments on long-term debt			(1,430,000)	(1,589,000)
Payments on line of credit			(8,900,000)	0
Advances on line of credit			10,900,000	1,400,000
Long-term debt financing			2,700,000
Principal payments on short-term financing			0	(202,000)
Capital contribution non-controlling interests			38,000	0
Distributions to non-controlling interests			(95,000)	0
Debt issuance costs long-term debt			(97,000)	(9,000)
Net cash provided by (used in) financing activities			3,116,000	(400,000)
Net change in cash, cash equivalents, and restricted cash			269,000	2,202,000
Cash, cash equivalents, and restricted cash at beginning of period			13,808,000	12,453,000
Cash, cash equivalents, and restricted cash at end of period	14,077,000	14,655,000	14,077,000	14,655,000
Supplemental cash flow disclosure
Interest			993,000	781,000
Income taxes			1,718,000	277,000
Schedule of noncash investing and financing activities
Equipment included in accounts payable and accrued liabilities			3,114,000	0
Non-controlling interest RI Acquisition	200,000		1,900,000	0
Detail of cash, cash equivalents and restricted cash at end of period
Cash and cash equivalents	13,827,000	14,537,000	13,827,000	14,537,000
Restricted cash	250,000	118,000	250,000	118,000
Cash, cash equivalents, and restricted cash at end of period	$ 14,077,000	$ 14,655,000	$ 14,077,000	$ 14,655,000